Recommendations for commissioning medicines and technologies where there is no NICE or national guidance, and resources to support the implementation of NICE Technology Appraisals.
Cannabis: Unlicensed cannabis-based medicines - Statement on prescribing in primary care.pdf
Pac Dibotermin Alfa For The Management Of Acute Tibial Fractures In Adults V3
EXOGEN® ultrasound bone healing system.zip
Management of hyperhidrosis.zip
Immune Check Point Inhibitor Induced Colitis.pdf
Faster acting insulin aspart (Fiasp®).pdf
Growth Hormone In Children.zip
Insulin degludec (Tresiba®).pdf
Insulin glargine 300 units_ml - Toujeo®.pdf
Iron chelators for iron overload in Myelodysplastic syndrome.pdf
PAC - IQoro neuromuscular training device v1.pdf
Liothyronine All Indications 10
Naltrexone and bupropion (Mysimba®) for obesity.pdf
Novel nicotine containing devices.pdf
Oxygen in cluster headaches.pdf
PCSK9 inhibitors Alirocumab and Evolocumab.zip
Psoriasis - biologic treatment of localised severe psoriasis.zip
Rifaximin for the management of chronic diarrhoea associated with gastro-intestinal disorders.pdf
Ritlecitinib for severe alopecia areata PAC recommendations v1.pdf
Thuasne Action Reliever Knee brace.pdf
Tolvaptan (Samsca®) for hyponatraemia secondary to SIADH.pdf
